Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMP | P19971 | 7/20 | 0.46 |
| ▸ | SLC29A1 | Q99808 | 5/20 | 0.41 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.38 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.38 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.38 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9231628 | 0.89 | TYMP (0.43) | TYMPSLC29A1 | |
| SCHEMBL9228567 | 0.85 | SLC29A1 (0.56) | SLC29A1 | |
| SCHEMBL9228575 | 0.85 | SLC29A1 (0.56) | SLC29A1 | |
| SCHEMBL7615989 | 0.85 | SLC29A1 (0.52) | TYMPSLC29A1 | |
| SCHEMBL7619002 | 0.85 | SLC29A1 (0.52) | TYMPSLC29A1 | |
| SCHEMBL7753897 | 0.84 | P2RY6 (0.40) | TYMP | |
| SCHEMBL8916283 | 0.81 | SLC29A1 (0.54) | SLC29A1 | |
| SCHEMBL8916276 | 0.81 | SLC29A1 (0.54) | SLC29A1 | |
| SCHEMBL8914132 | 0.81 | SLC29A1 (0.43) | TYMPSLC29A1 | |
| SCHEMBL9230969 | 0.80 | P2RY6 (0.41) | TYMP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0661291-B1 | Solid phase synthesis of oligoribonucleotide | AVENTIS PHARMA GMBH (DE) | 2001-03-07 | — | — | EP | disclosed |
| EP-0661291-A1 | Solid phase synthesis of oligoribonucleotide | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-07-05 | — | — | EP | disclosed |